Frank Tacke

University Name

Research Interests

Explore related searches

Contact this professor

Google Scholar

Articles (31)

Collaborators (17)

Isabella Lurje

Medizinische Fakultät der RWTH Aachen

Georg Lurje

Deputy Director, Head of Liver- and Transplantation Surgery

University Hospital Heidelberg

Tobias Puengel

Charité - Universitätsmedizin Berlin

Aleksander Krag

Odense University Hospital

Scott Friedman

Dean for Therapeutic Discovery

Icahn School of Medicine at Mount Sinai

UNITED STATES

Alexander Zipprich

Jonel Trebicka

Dominik Geisel

Prakash Ramachandran

Professor of Experimental Hepatology

University of Edinburgh

UNITED KINGDOM

Raphael Mohr

Charité - Universitätsmedizin Berlin

Julian Pohl

Charité - Universitätsmedizin Berlin

Eva Katrin Wirth

Markus Peck‐Radosavljevic

Paul Horn

Alexander Wree

Charité - Universitätsmedizin Berlin

Ralf Weiskirchen

Medizinische Fakultät der RWTH Aachen

Thomas Reiberger

Medical University of Vienna

Frank Tacke

Research Interests

Explore related searches

Contact this professor

Articles (31)

Antifibrotic therapies for metabolic dysfunction-associated steatotic liver disease

Letter: Comparing the Efficacy of Adjuvant PD–1 Inhibitor After Curative Resection for Metabolic Dysfunction‐Associated Steatotic Liver Disease Related HCC Versus Other Aetiologies—Authors' Reply

Dissecting the immune pathogenesis of HBV-ACLF through single-cell multimodal analysis

Immune pathology in paediatric acute hepatitis of unknown origin — uncovering the link to COVID-19

Liver biopsy and acute hepatology in intensive care unit patients

Steatotische Lebererkrankung mit metabolischer Funktionsstörung – die neue Nomenklatur zur Fettleber im deutschen Kontext

Emerging Trends in Patients Hospitalised With Cirrhosis—Aetiologies, Complications and Outcomes Compared to Other Chronic Health Conditions

Immunopathogenic mechanisms and immunoregulatory therapies in MASLD

Reviewing the function of macrophages in liver disease

Faecal Cytolysin is Associated With Worse Survival in Patients With Primary Sclerosing Cholangitis

Hepatic immune regulation and sex disparities

Metabolic reprogramming in liver fibrosis

Impact of non‐selective beta blockers on further decompensation and death in decompensated cirrhosis: Benefit and risk stratification by MELD score

Angiocrine signaling in sinusoidal homeostasis and liver diseases

Impact of peripheral thyroid hormone balance on liver fat: insights from the NutriAct trial

High disease burden and healthcare resource usage in patients with acute porphyria—A population‐based analysis

Liver macrophages revisited: The expanding universe of versatile responses in a spatiotemporal context

Steatotische Lebererkrankung mit metabolischer Funktionsstörung – die neue Nomenklatur zur Fettleber im deutschen Kontext

Exploring the role of macrophages in the pathogenesis of alcohol-associated liver disease

Pharmacotherapeutic options for metabolic dysfunction-associated steatotic liver disease: where are we today?

Mechanisms of organ fibrosis: Emerging concepts and implications for novel treatment strategies.

Painless jaundice with segmental obstructive cholestasis

Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma: Results from a German real‐world cohort

An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH

Efruxifermin, an investigational treatment for fibrotic or cirrhotic nonalcoholic steatohepatitis (NASH)

Limited access to liver transplantation and TIPS despite high mortality, healthcare resource use and costs of cirrhosis in Germany

Use of albumin infusion for cirrhosis-related complications

Somatic mutant clone screening: scan for novel NASH target genes in mouse liver

At the dawn of potent therapeutics for fatty liver disease – introducing the miniseries on promising pharmacological targets for NASH

Hepatic inflammatory responses in liver fibrosis

Editorial: prevalence, progression rates and mortality predictors of non‐alcoholic fatty liver disease reflected by German statutory health insurance data

Collaborators (17)

Isabella Lurje

Georg Lurje

Tobias Puengel

Aleksander Krag

Scott Friedman

Alexander Zipprich

Jonel Trebicka

Dominik Geisel

Prakash Ramachandran

Raphael Mohr

Julian Pohl

Eva Katrin Wirth

Markus Peck‐Radosavljevic

Paul Horn

Alexander Wree

Ralf Weiskirchen

Thomas Reiberger

How do I reach out?

Meet Kite AI